Dysregulated PRKAA1 expression is linked to several ER stress-related diseases, including metabolic disorders (e.g., diabetes, cardiovascular diseases) and tumor invasiveness (Yong et al., 2024; Zhang et al., 2022; Shao et al., 2024). This evidence concerns the gene PRKAA1 and cardiovascular disorder.